4.5 Article

Effects of modified risk tobacco product claims on consumer comprehension and risk perceptions of IQOS

Journal

TOBACCO CONTROL
Volume 31, Issue E1, Pages E41-E49

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/tobaccocontrol-2020-056191

Keywords

harm reduction; advertising and promotion; nicotine

Funding

  1. National Cancer Institute of the National Institutes of Health and the Food and Drug Administration Centre for Tobacco Products [R00CA187460]
  2. National Institute on Drug Abuse of the National Institutes of Health and the Food and Drug Administration Centre for Tobacco Products [P50DA036128, R01DA047397]

Ask authors/readers for more resources

This study examined the effects of IQOS MRCs on risk perceptions and behavioral intentions of smokers and non-smokers. The results showed that including an explanation about 'switching completely' in MRCs can lead more smokers to understand it as quitting smoking, while certain language features may mislead consumers into believing that a product reduces the risk of diseases not mentioned in MRCs.
Introduction Tobacco industry studies on consumers' perceptions of modified risk claims (MRCs) often had important omissions (eg, no control group, not investigating whether consumers understand what 'switching completely' means). This study examined the effects of IQOS MRCs on risk perceptions and behavioural intentions. Method Based on tobacco companies' MRCs, we manipulated three MRC language features: explanation about 'switching completely' (absent vs present), number of diseases (single vs multiple) and language certainty (hypothetical vs certain). In an online experiment, we randomised 1523 US adult current smokers and 1391 young adult non-smokers to 1 of 9 conditions following a 2x2x2+1 control design. People reported their comprehension of 'switching completely', IQOS risk perceptions and behavioural intentions after message exposure. Results More smokers exposed to MRCs that included an explanation about 'switching completely' (22.2%) (vs explanation absent (11.2%) and control (10.7%)) mentioned that 'switching completely' meant smoking 0 cigarettes. Compared with the control, several MRCs (eg, certain language) produced lower perceived risk of IQOS, including for diseases not mentioned in the MRCs. MRCs using certain and hypothetical language did not differ on any outcomes. MRCs highlighting reduced risk for a single disease and multiple diseases did not differ on any outcomes. MRCs did not influence behavioural intentions. Conclusion The Food and Drug Administration should ensure that consumers understand what 'switching completely' means in an MRC and recognize that some language features may mislead consumers into believing that a product reduces the risk of diseases not mentioned in an MRC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available